Literature DB >> 32393869

Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression.

Simon W Hayward1, Gustavo Ayala2, Alexander R A Anderson3, Ziv Frankenstein4,5, David Basanta4, Omar E Franco1, Yan Gao2, Rodrigo A Javier1, Douglas W Strand6, MinJae Lee7.   

Abstract

Prostate cancer (PCa) progression is a complex eco-evolutionary process driven by the feedback between evolving tumour cell phenotypes and microenvironmentally driven selection. To better understand this relationship, we used a multiscale mathematical model that integrates data from biology and pathology on the microenvironmental regulation of PCa cell behaviour. Our data indicate that the interactions between tumour cells and their environment shape the evolutionary dynamics of PCa cells and explain overall tumour aggressiveness. A key environmental determinant of this aggressiveness is the stromal ecology, which can be either inhibitory, highly reactive (supportive) or non-reactive (neutral). Our results show that stromal ecology correlates directly with tumour growth but inversely modulates tumour evolution. This suggests that aggressive, environmentally independent PCa may be a result of poor stromal ecology, supporting the concept that purely tumour epithelium-centric metrics of aggressiveness may be incomplete and that incorporating markers of stromal ecology would improve prognosis.

Entities:  

Mesh:

Year:  2020        PMID: 32393869     DOI: 10.1038/s41559-020-1157-y

Source DB:  PubMed          Journal:  Nat Ecol Evol        ISSN: 2397-334X            Impact factor:   19.100


  54 in total

Review 1.  The role of the basement membrane as a modulator of intestinal epithelial-mesenchymal interactions.

Authors:  P Simon-Assmann; C Spenle; O Lefebvre; M Kedinger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.

Authors:  Jennifer A Tuxhorn; Stephanie J McAlhany; Truong D Dang; Gustavo E Ayala; David R Rowley
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

Review 3.  Reactive stroma in prostate cancer progression.

Authors:  J A Tuxhorn; G E Ayala; D R Rowley
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

4.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

Review 5.  Perspectives on tissue interactions in development and disease.

Authors:  D W Strand; O E Franco; D Basanta; A R A Anderson; S W Hayward
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

6.  Identification of fibroblast heterogeneity in the tumor microenvironment.

Authors:  Hikaru Sugimoto; Thomas M Mundel; Mark W Kieran; Raghu Kalluri
Journal:  Cancer Biol Ther       Date:  2006-12-05       Impact factor: 4.742

7.  Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis.

Authors:  Omar E Franco; Ming Jiang; Douglas W Strand; James Peacock; Suzanne Fernandez; Roger S Jackson; Monica P Revelo; Neil A Bhowmick; Simon W Hayward
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

Review 8.  Epithelial-stromal interactions in the mouse and human mammary gland in vivo.

Authors:  Hema Parmar; Gerald R Cunha
Journal:  Endocr Relat Cancer       Date:  2004-09       Impact factor: 5.678

9.  Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.

Authors:  Gustavo Ayala; Jennifer A Tuxhorn; Thomas M Wheeler; Anna Frolov; Peter T Scardino; Makoto Ohori; Marcus Wheeler; Jeffrey Spitler; David R Rowley
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

10.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  10 in total

Review 1.  Fibroblast heterogeneity in prostate carcinogenesis.

Authors:  Sathyavathi ChallaSivaKanaka; Renee E Vickman; Mamatha Kakarla; Simon W Hayward; Omar E Franco
Journal:  Cancer Lett       Date:  2021-10-29       Impact factor: 8.679

Review 2.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

Review 3.  Materials-driven approaches to understand extrinsic drug resistance in cancer.

Authors:  Justin R Pritchard; Michael J Lee; Shelly R Peyton
Journal:  Soft Matter       Date:  2022-05-11       Impact factor: 4.046

Review 4.  Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance.

Authors:  Rongbin Ge; Zongwei Wang; Liang Cheng
Journal:  NPJ Precis Oncol       Date:  2022-05-04

Review 5.  Synthetic gut microbiome: Advances and challenges.

Authors:  Humphrey A Mabwi; Eunjung Kim; Dae-Geun Song; Hyo Shin Yoon; Cheol-Ho Pan; Erick V G Komba; GwangPyo Ko; Kwang Hyun Cha
Journal:  Comput Struct Biotechnol J       Date:  2020-12-24       Impact factor: 7.271

6.  Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients.

Authors:  Ina P Pavlova; Sujit S Nair; Dara Lundon; Stanislaw Sobotka; Reza Roshandel; Patrick-Julien Treacy; Parita Ratnani; Rachel Brody; Jonathan I Epstein; Gustavo E Ayala; Natasha Kyprianou; Ashutosh K Tewari
Journal:  J Pers Med       Date:  2021-10-22

7.  The impact of the spatial heterogeneity of resistant cells and fibroblasts on treatment response.

Authors:  Masud M A; Jae-Young Kim; Cheol-Ho Pan; Eunjung Kim
Journal:  PLoS Comput Biol       Date:  2022-03-09       Impact factor: 4.475

Review 8.  Small extracellular vesicle DNA-mediated horizontal gene transfer as a driving force for tumor evolution: Facts and riddles.

Authors:  Gábor Valcz; Beáta Újvári; Edit I Buzás; Tibor Krenács; Sándor Spisák; Ágnes Kittel; Zsolt Tulassay; Péter Igaz; István Takács; Béla Molnár
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

Review 9.  Second generation androgen receptor antagonists and challenges in prostate cancer treatment.

Authors:  Yanhua Chen; Qianqian Zhou; William Hankey; Xiaosheng Fang; Fuwen Yuan
Journal:  Cell Death Dis       Date:  2022-07-21       Impact factor: 9.685

Review 10.  Understanding breast cancer heterogeneity through non-genetic heterogeneity.

Authors:  Neda Barzgar Barough; Fakhrosadat Sajjadian; Nazila Jalilzadeh; Hajar Shafaei; Kobra Velaei
Journal:  Breast Cancer       Date:  2021-03-15       Impact factor: 4.239

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.